Table 3.
The distribution of pharmacy interventions according to age and gender versus hospital ward.
| 3A. The distribution of pharmacy interventions according to age versus hospital ward | ||||
| Change in resource use | Emergency | Critical care | General internal medicine | Total |
| Adult; n (%) | 117 (13.64) | 142 (16.55) | 338 (39.39) | 597 (69.58) |
| Addition of a diagnostic test | 0 (0) | 2 (0.23) | 4 (0.47) | 6 (0.7) |
| Addition of a lab test | 5 (0.58) | 6 (0.7) | 12 (1.4) | 23 (2.68) |
| Addition of a prophylactic agent | 2 (0.23) | 0 (0) | 16 (1.86) | 18 (2.1) |
| Therapeutic drug monitoring | 5 (0.58) | 6 (0.7) | 12 (1.4) | 23 (2.68) |
| Addition of a vaccine | 3 (0.35) | 2 (0.23) | 0 (0) | 5 (0.58) |
| Addition of another medication | 25 (2.91) | 41 (4.78) | 94 (10.96) | 160 (18.65) |
| Change in a medication route | 10 (11.76) | 12 (1.4) | 16 (1.86) | 38 (4.43) |
| Change in a medication strength | 7 (0.82) | 5 (0.58) | 23 (2.68) | 35 (41.18) |
| Decrease in a medication dose | 6 (0.7) | 10 (1.17) | 21 (2.45) | 37 (4.31) |
| Decrease in a medication duration | 4 (0.47) | 1 (0.12) | 2 (0.23) | 7 (0.82) |
| Decrease in a medication frequency | 2 (0.23) | 2 (0.23) | 11 (1.28) | 15 (1.75) |
| Discontinuation of a medication | 30 (3.5) | 21 (2.45) | 58 (6.76) | 109 (12.70) |
| Increase in a medication dose | 8 (0.93) | 14 (1.63) | 23 (2.68) | 45 (5.24) |
| Increase in medication duration | 5 (0.58) | 6 (0.7) | 16 (1.86) | 27 (3.15) |
| Increase in medication frequency | 2 (0.23) | 6 (0.7) | 11 (1.28) | 19 (2.21) |
| Switching to alternative medication | 3 (0.35) | 8 (0.93) | 19 (2.21) | 30 (3.50) |
| Elderly; n (%) | 29 (3.38) | 111 (12.94) | 121 (14.10) | 261 (30.42) |
| Addition of a culture test | 0 (0) | 1 (0.12) | 1 (0.12) | 2 (0.23) |
| Addition of a diagnostic test | 0 (0) | 1 (0.12) | 0 (0) | 1 (0.12) |
| Addition of a lab test | 1 (0.12) | 1 (0.12) | 5 (0.58) | 7 (0.82) |
| Addition of a prophylactic agent | 0 (0) | 5 (0.58) | 12 (1.4) | 17 (1.98) |
| Therapeutic drug monitoring | 2 (0.23) | 1 (0.12) | 5 (0.58) | 8 (0.93) |
| Addition of a vaccine | 0 (0) | 0 (0) | 1 (0.12) | 1 (0.12) |
| Addition of another medication | 8 (0.93) | 31 (3.61) | 30 (3.50) | 69 (8.04) |
| Change in medication route | 2 (0.23) | 5 (0.58) | 5 (0.58) | 12 (1.40) |
| Change in medication strength | 0 (0) | 3 (0.35) | 4 (0.47) | 7 (0.82) |
| Decrease in medication dose | 5 (0.58) | 11 (1.28) | 10 (1.17) | 26 (3.03) |
| Decrease in medication duration | 0 (0) | 1 (0.12) | 0 (0) | 1 (0.12) |
| Decrease in medication frequency | 1 (0.12) | 6 (0.7) | 5 (0.58) | 12 (1.40) |
| Discontinuation of a medication | 7 (0.82) | 16 (3.2) | 26 (3.03) | 49 (5.71) |
| Increase in medication dose | 0 (0) | 20 (2.33) | 5 (0.58) | 25 (2.91) |
| Increase in medication duration | 0 (0) | 0 (0) | 4 (0.47) | 4 (0.47) |
| Increase in medication frequency | 0 (0) | 5 (0.58) | 4 (0.47) | 9 (1.05) |
| Switching to alternative medication | 3 (0.35) | 4 (0.47) | 4 (0.47) | 11 (12.94) |
| 3B. The distribution of pharmacy interventions according to gender versus hospital ward. | ||||
| Count of type of change in resources | Emergency | Critical care | General internal medicine | Total |
| Female; n (%) | 10 | 78 | 81 | 169 |
| Addition of a culture test | 0 (0) | 1 (0.12) | 1 (0.12) | 2 (0.23) |
| Addition of a lab test | 0 (0) | 4 (0.47) | 3 (0.35) | 7 (0.82) |
| Addition of a prophylactic agent | 0 (0) | 1 (0.12) | 5 (0.58) | 6 (0.7) |
| Therapeutic drug monitoring | 1 (0.12) | 0 (0) | 2 (0.23) | 3 (0.35) |
| Addition of a vaccine | 0 (0) | 0 (0) | 1 (0.12) | 1 (0.12) |
| Addition of another medication | 7 (0.82) | 20 (2.33) | 22 (2.56) | 49 (5.71) |
| Change in medication route | 0 (0) | 7 (0.82) | 5 (0.58) | 12 (1.40) |
| Change in medication strength | 0 (0) | 3 (0.35) | 6 (0.7) | 9 (1.05) |
| Decrease in medication dose | 0 (0) | 6 (0.7) | 4 (0.47) | 10 (1.17) |
| Decrease in medication duration | 0 (0) | 2 (0.23) | 0 (0) | 2 (0.23) |
| Decrease in medication frequency | 0 (0) | 2 (0.23) | 1 (0.12) | 3 (0.35) |
| Discontinuation of a medication | 1 (0.12) | 15 (1.75) | 17 (1.98) | 33 (3.85) |
| Increase in medication dose | 1 (0.12) | 8 (0.93) | 4 (0.47) | 13 (1.52) |
| Increase in medication duration | 0 (0) | 4 (0.47) | 4 (0.47) | 8 (0.93) |
| Increase in medication frequency | 0 (0) | 1 (0.12) | 4 (0.47) | 5 (0.58) |
| Switching to alternative medication | 0 (0) | 4 (0.47) | 2 (0.23) | 6 (0.7) |
| Male; n (%) | 136 (15.85) | 175 (20.40) | 378 (44.06) | 689 (80.30) |
| Addition of a diagnostic test | 0 (0) | 3 (0.35) | 4 (0.47) | 7 (0.82) |
| Addition of a lab test | 6 (0.7) | 3 (0.35) | 14 (1.63) | 23 (2.68) |
| Addition of a prophylactic agent | 2 (0.23) | 4 (0.47) | 23 (2.68) | 29 (3.38) |
| Therapeutic drug monitoring | 6 (0.7) | 7 (0.82) | 15 (17.65) | 28 (3.26) |
| Addition of a vaccine | 3 (0.35) | 2 (0.23) | 0 (0) | 5 (0.58) |
| Addition of another medication | 26 (3.03) | 52 (6.06) | 102 (11.89) | 180 (20.98) |
| Change in medication route | 12 (1.40) | 10 (1.17) | 16 (1.86) | 38 (4.43) |
| Change in medication strength | 7 (0.82) | 5 (0.58) | 21 (2.45) | 33 (3.85) |
| Decrease in medication dose | 11 (1.28) | 15 (1.75) | 27 (3.15) | 53 (6.18) |
| Decrease in medication duration | 4 (0.47) | 0 (0) | 2 (0.23) | 6 (0.7) |
| Decrease in medication frequency | 3 (0.35) | 6 (0.7) | 15 (1.75) | 24 (2.80) |
| Discontinuation of a medication | 36 (42.35) | 22 (2.56) | 67 (7.81) | 125 (14.57) |
| Increase in medication dose | 7 (0.82) | 26 (3.03) | 24 (2.80) | 57 (0.58) |
| Increase in medication duration | 5 (0.58) | 2 (0.23) | 16 (1.86) | 23 (2.78) |
| Increase in medication frequency | 2 (0.23) | 10 (1.17) | 11 (1.28) | 23 (2.68) |
| Switching to alternative medication | 6 (0.7) | 8 (0.93) | 21 (2.45) | 35 (4.08) |